多西紫杉醇或长春瑞滨单用或联合曲妥珠单抗用于早期乳腺癌辅助治疗

沈坤炜; 王坤; 林文

doi:10.3969/j.issn.1671-5144.2008.03.002

沈坤炜, 王坤, 林文. 多西紫杉醇或长春瑞滨单用或联合曲妥珠单抗用于早期乳腺癌辅助治疗[J]. 循证医学, 2008, 8(3): 132-134. DOI: 10.3969/j.issn.1671-5144.2008.03.002

引用本文:

沈坤炜, 王坤, 林文. 多西紫杉醇或长春瑞滨单用或联合曲妥珠单抗用于早期乳腺癌辅助治疗[J]. 循证医学, 2008, 8(3): 132-134. DOI: 10.3969/j.issn.1671-5144.2008.03.002

SHEN Kun-wei, WANG Kun, LIN Wen. Adjuvant Docetaxel or Vinorelbine with or without Trastu-zumab for Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 132-134. DOI: 10.3969/j.issn.1671-5144.2008.03.002

Citation:

SHEN Kun-wei, WANG Kun, LIN Wen. Adjuvant Docetaxel or Vinorelbine with or without Trastu-zumab for Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 132-134. DOI: 10.3969/j.issn.1671-5144.2008.03.002

多西紫杉醇或长春瑞滨单用或联合曲妥珠单抗用于早期乳腺癌辅助治疗

Adjuvant Docetaxel or Vinorelbine with or without Trastu-zumab for Breast Cancer

摘要

HTML全文

参考文献(0)

资源附件(0)

/